International pharmaceutical biosimilarity
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: JACKSON-MATTHEWS, Dianne (ERA Consulting (Australia) Pty Ltd, Regulatory Affairs, Toowong, Australia)
Innovative products of recombinant DNA technology, such as cytokines, fusion proteins and monoclonal antibodies, have risen to a position of relative dominance in the global pharmaceutical market. With the support of increasingly sophisticated pharmaceutical and analytical methodologies, these products, where permitted by patent expirations, may.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.